Bronwen Bastone - 03 Mar 2025 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
ENFN
Transactions as of
03 Mar 2025
Transactions value $
-$23,697
Form type
4
Filing time
05 Mar 2025, 18:17:12 UTC
Previous filing
28 Feb 2025
Next filing
07 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale -$23.7K -2.06K -0.91% $11.48 225K 03 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares and does not represent discretionary trades by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.429 to $11.535. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.